RxDoctor Payments Data

Sheena McElhaney, PA

Physician Assistant · Hattiesburg, MSNPI 1538242144

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.

$3,742in general payments, 2019–2025

Across 223 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$771
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$516
  • AstraZeneca$297
  • Boehringer Ingelheim$287
  • Merck$280
  • E.r. Squibb & Sons, L.L.C.$267
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,742100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,742 in reported general payments places this provider in the 80th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$109,666
Medicare patients
913
Services billed
2,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$85,094
EntrestoSacubitril/Valsartan57$47,665
XareltoRivaroxaban46$38,415
BrilintaTicagrelor53$29,108
JardianceEmpagliflozin27$22,249
MultaqDronedarone Hcl13$11,115
FarxigaDapagliflozin Propanediol15$6,976
Dofetilide32$4,247
Ranolazine ErRanolazine99$4,161
Metoprolol Succinate204$2,279
Isosorbide Mononitrate ErIsosorbide Mononitrate233$2,020
Midodrine Hcl26$1,475
Flecainide Acetate34$1,387
Nitroglycerin61$1,270
Atorvastatin Calcium161$1,065

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$151$85,094117 claims
NovartisEntresto$771$47,66557 claims
Johnson & JohnsonXarelto$127$38,41546 claims
AstraZenecaBrilinta, Farxiga$297$36,08468 claims
Boehringer IngelheimJardiance$287$22,24927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →